Satraplatin

DRUG10 trials

Conditions

Advanced CancersBrain MetastasesBrain TumorsCarcinoma, Non-small Cell LungGenetic PolymorphismHormone Refractory Prostate CancerLung CancerMetastatic Breast Cancer

Phase 1

Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy

TerminatedNCT00093132

AgennixCarcinoma, Non-small Cell Lung, Lung Cancer

Start: 2004-08-31End: 2009-02-28Updated: 2012-08-17

A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel

TerminatedNCT00313456

AgennixProstate Cancer, Tumors

Start: 2006-03-31End: 2009-03-31Updated: 2012-05-10

Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers

CompletedNCT00473720

Yale UniversityAdvanced Cancers

Start: 2007-05-31End: 2010-06-30Updated: 2013-01-23

Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors

CompletedNCT01259479

National Cancer Institute (NCI)Brain Metastases, Brain Tumors, Solid Tumors

Start: 2010-12-03End: 2015-05-29Updated: 2018-07-05

Phase 2

Satraplatin for Patients With Metastatic Breast Cancer (MBC)

CompletedNCT00265655

AgennixMetastatic Breast Cancer

Start: 2005-11-30End: 2008-02-29Updated: 2012-03-28

A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)

CompletedNCT00370383

AgennixLung Cancer

Start: 2006-07-31End: 2009-03-31Updated: 2012-08-07

Satraplatin and Prednisone to Treat Prostate Cancer

CompletedNCT00634647

National Cancer Institute (NCI)Genetic Polymorphism, Prostate Cancer

Start: 2008-02-19End: 2012-05-01Updated: 2018-10-02

Utilizing A Genomic Sig for BRCAness to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca

CompletedNCT01289067

William K. OhProstate Cancer

Start: 2010-12-31End: 2013-05-31Updated: 2018-02-13

Phase 3

Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen

CompletedNCT00069745

AgennixHormone Refractory Prostate Cancer, Prostate Cancer

Start: 2003-09-30End: 2007-03-31Updated: 2012-08-07

Unknown Phase

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

CompletedNCT00499694

Barbara Ann Karmanos Cancer InstituteProstate Cancer

Start: 2007-10-31End: 2012-11-30Updated: 2018-06-12

Related Papers

Biomarker development trial of satraplatin in patients with metastatic castrate-resistant prostate cancer.

Journal of Clinical Oncology2014-02-01